Protheragen-ING Lab has a quality management system for pharmaceutical safety evaluation based on internationally recognized quality standards and in compliance with international and domestic GLP regulations. Since its inception, we have continued to move closer to international standards to accomplish high-quality pharmaceutical safety testing services.
We are committed to ensuring the safety and efficacy of pharmaceutical products through comprehensive and reliable safety testing. Our team consists of experienced scientists and state-of-the-art facilities capable of handling a wide range of safety assessments. We prioritize scientific excellence, compliance, and timely delivery of results. By working with us, you can be confident in the safety and quality of your medicines.
We can provide you with the following pharmaceutical safety testing programs, including but not limited to:
Our experts provide support in the early stages of drug development by conducting safety evaluations on lead compounds. We analyze the chemical structure, physicochemical properties, and potential toxicity risks of the compounds, helping you make informed decisions on which candidates to pursue.
We assess the Absorption, Distribution, Metabolism, and Excretion (ADME) properties of your drug candidates to understand how they are absorbed, distributed, metabolized, and eliminated within the body. This information is crucial for determining their bioavailability, potential interactions, and overall pharmacokinetic profile.
Our comprehensive toxicology studies include assessments of acute toxicity, sub-chronic toxicity, chronic toxicity, and carcinogenicity. These studies evaluate the potential adverse effects of your drug candidates on various organ systems, helping you identify any safety concerns.
We conduct genetic toxicology studies to assess the potential for your drug candidates to cause DNA damage or mutations. These studies include tests for gene mutations, chromosomal aberrations, and DNA damage, ensuring the safety of your compounds on a genetic level.
Our safety pharmacology studies evaluate the potential effects of your drug candidates on vital organ systems, such as the cardiovascular, respiratory, and central nervous systems. These studies provide valuable insights into the safety profile and potential side effects of your compounds.
We assess the impact of your drug candidates on the immune system through immunotoxicology studies. These evaluations help determine any potential immunosuppressive or immunostimulatory effects, ensuring the overall safety and efficacy of your pharmaceutical products.
Our PK studies analyze the absorption, distribution, metabolism, and excretion of your drug candidates in the body. By understanding how the compounds move within the system, we can provide valuable information on optimal dosing regimens, bioavailability, and potential drug-drug interactions.
We evaluate the pharmacodynamic effects of your drug candidates, which involve assessing their interactions with target receptors and their impact on physiological processes. These studies provide insights into the mechanism of action, efficacy, and potential side effects of your compounds.
We help our clients address any potential risks early in the development of their pharmaceutical products so that they can produce medicines of the highest quality, strength, and purity without sacrificing safety. No matter what stage your product is currently at, we can help you based on our GMP drug safety testing laboratory services and expert consulting team.
With years of experience, we continue to help our clients expand their knowledge and understanding of pharmaceuticals, particularly in relation to regulatory requirements and can ensure that all medicines meet the highest quality, safety and performance requirements.
Contact us today to learn more about our pharmaceutical safety testing services and how we can assist you in navigating the complex landscape of drug development.